STOCK TITAN

[144] Zai Lab Limited American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Zai Lab Limited insider sale disclosure: The filing notifies a proposed sale of 1,883 American Depositary Shares (ADS) with an aggregate market value of $68,232.95, to be sold approximately on 08/18/2025 on NASDAQ. The ADS were acquired on 08/15/2025 by restricted stock vesting from the issuer and the consideration is listed as compensation.

The filer also reported a prior sale by the same person on 06/26/2025 of 5,877 ADS for $212,344.83. The notice includes the required representation that the selling person does not possess undisclosed material adverse information about the issuer.

Comunicazione di vendita interna di Zai Lab Limited: La dichiarazione segnala la proposta di vendita di 1.883 American Depositary Shares (ADS) per un valore di mercato complessivo di $68.232,95, da realizzarsi approssimativamente il 18/08/2025 sul NASDAQ. Le ADS sono state acquisite il 15/08/2025 tramite vesting di azioni soggette a restrizioni dall'emittente e la contropartita è indicata come compenso.

Il dichiarante ha inoltre riportato una precedente vendita da parte della stessa persona il 26/06/2025 di 5.877 ADS per $212.344,83. L’avviso include la rappresentazione richiesta che la persona che vende non è in possesso di informazioni negative rilevanti non divulgate sull'emittente.

Divulgación de venta de un insider de Zai Lab Limited: El documento notifica la propuesta de venta de 1.883 American Depositary Shares (ADS) con un valor de mercado agregado de $68.232,95, prevista aproximadamente para el 18/08/2025 en NASDAQ. Las ADS fueron adquiridas el 15/08/2025 mediante vesting de acciones restringidas del emisor y la contraprestación se indica como compensación.

El declarante también informó de una venta anterior realizada por la misma persona el 26/06/2025 de 5.877 ADS por $212.344,83. El aviso incluye la declaración requerida de que la persona vendedora no posee información adversa material no divulgada sobre el emisor.

Zai Lab Limited 내부자 매도 공시: 해당 서류는 1,883주의 American Depositary Shares(ADS)를 총 시장가치 $68,232.95로 약 2025-08-18에 NASDAQ에서 매도할 예정임을 알립니다. 해당 ADS는 2025-08-15에 발행사로부터 제한부 주식 베스팅(vesting)으로 취득되었으며 대가는 보수(compensation)로 기재되어 있습니다.

신고인은 같은 사람이 2025-06-265,877 ADS$212,344.83에 매도한 사실도 보고했습니다. 공시에는 매도인이 발행사에 대해 미공개 중대한 불리한 정보를 보유하고 있지 않다는 필수 진술이 포함되어 있습니다.

Divulgation de vente par un initié de Zai Lab Limited : Le dépôt signale la proposition de vente de 1 883 American Depositary Shares (ADS) pour une valeur de marché totale de 68 232,95 $, devant être réalisée approximativement le 18/08/2025 sur le NASDAQ. Les ADS ont été acquises le 15/08/2025 par vesting d'actions restreintes de l'émetteur et la contrepartie est indiquée comme rémunération.

Le déclarant a également signalé une vente antérieure par la même personne le 26/06/2025 de 5 877 ADS pour 212 344,83 $. L'avis inclut la déclaration requise selon laquelle la personne vendant ne détient pas d'informations défavorables importantes non divulguées concernant l'émetteur.

Offenlegung eines Insider-Verkaufs von Zai Lab Limited: Die Einreichung meldet den geplanten Verkauf von 1.883 American Depositary Shares (ADS) mit einem gesamten Marktwert von $68.232,95, voraussichtlich am 18.08.2025 an der NASDAQ. Die ADS wurden am 15.08.2025 durch restricted stock vesting vom Emittenten erworben und die Gegenleistung ist als Vergütung angegeben.

Der Einreichende berichtete außerdem über einen früheren Verkauf derselben Person am 26.06.2025 von 5.877 ADS für $212.344,83. Die Mitteilung enthält die erforderliche Zusicherung, dass die veräußernde Person keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten besitzt.

Positive
  • Transparent compliance: The filer provided required Rule 144 details including acquisition method, broker, and planned sale date.
  • Disclosure of prior sales: The filing reports a recent sale on 06/26/2025 (5,877 ADS for $212,344.83), improving transparency about insider transactions.
Negative
  • Insider liquidity: The insider sold ADS recently (5,877 on 06/26/2025 and proposing 1,883 on 08/18/2025), which some investors may view negatively despite small absolute amounts.

Insights

TL;DR: Routine Rule 144 disclosure for insider compensation shares; volumes are small relative to outstanding ADS.

The filing documents a planned sale of 1,883 ADS received via restricted stock vesting, valued at $68,232.95, with an outstanding ADS count reported as 421,725,450. The transaction appears to be a routine disposition of compensation-related shares under Rule 144 rather than an event tied to operational developments. Recent prior sale of 5,877 ADS for $212,344.83 is disclosed, which together with the current notice represents modest insider liquidity but is immaterial versus total outstanding ADS.

TL;DR: Proper Rule 144 procedural disclosure; includes required represenation about material nonpublic information.

The notice fulfills procedural requirements by identifying the nature of acquisition (restricted stock vesting), amount, and broker details (Fidelity Brokerage Services). It confirms the signer represents no undisclosed material adverse information, and documents a prior related sale within three months. From a governance perspective, the filing is compliant and transparent for an insider compensation-related sale.

Comunicazione di vendita interna di Zai Lab Limited: La dichiarazione segnala la proposta di vendita di 1.883 American Depositary Shares (ADS) per un valore di mercato complessivo di $68.232,95, da realizzarsi approssimativamente il 18/08/2025 sul NASDAQ. Le ADS sono state acquisite il 15/08/2025 tramite vesting di azioni soggette a restrizioni dall'emittente e la contropartita è indicata come compenso.

Il dichiarante ha inoltre riportato una precedente vendita da parte della stessa persona il 26/06/2025 di 5.877 ADS per $212.344,83. L’avviso include la rappresentazione richiesta che la persona che vende non è in possesso di informazioni negative rilevanti non divulgate sull'emittente.

Divulgación de venta de un insider de Zai Lab Limited: El documento notifica la propuesta de venta de 1.883 American Depositary Shares (ADS) con un valor de mercado agregado de $68.232,95, prevista aproximadamente para el 18/08/2025 en NASDAQ. Las ADS fueron adquiridas el 15/08/2025 mediante vesting de acciones restringidas del emisor y la contraprestación se indica como compensación.

El declarante también informó de una venta anterior realizada por la misma persona el 26/06/2025 de 5.877 ADS por $212.344,83. El aviso incluye la declaración requerida de que la persona vendedora no posee información adversa material no divulgada sobre el emisor.

Zai Lab Limited 내부자 매도 공시: 해당 서류는 1,883주의 American Depositary Shares(ADS)를 총 시장가치 $68,232.95로 약 2025-08-18에 NASDAQ에서 매도할 예정임을 알립니다. 해당 ADS는 2025-08-15에 발행사로부터 제한부 주식 베스팅(vesting)으로 취득되었으며 대가는 보수(compensation)로 기재되어 있습니다.

신고인은 같은 사람이 2025-06-265,877 ADS$212,344.83에 매도한 사실도 보고했습니다. 공시에는 매도인이 발행사에 대해 미공개 중대한 불리한 정보를 보유하고 있지 않다는 필수 진술이 포함되어 있습니다.

Divulgation de vente par un initié de Zai Lab Limited : Le dépôt signale la proposition de vente de 1 883 American Depositary Shares (ADS) pour une valeur de marché totale de 68 232,95 $, devant être réalisée approximativement le 18/08/2025 sur le NASDAQ. Les ADS ont été acquises le 15/08/2025 par vesting d'actions restreintes de l'émetteur et la contrepartie est indiquée comme rémunération.

Le déclarant a également signalé une vente antérieure par la même personne le 26/06/2025 de 5 877 ADS pour 212 344,83 $. L'avis inclut la déclaration requise selon laquelle la personne vendant ne détient pas d'informations défavorables importantes non divulguées concernant l'émetteur.

Offenlegung eines Insider-Verkaufs von Zai Lab Limited: Die Einreichung meldet den geplanten Verkauf von 1.883 American Depositary Shares (ADS) mit einem gesamten Marktwert von $68.232,95, voraussichtlich am 18.08.2025 an der NASDAQ. Die ADS wurden am 15.08.2025 durch restricted stock vesting vom Emittenten erworben und die Gegenleistung ist als Vergütung angegeben.

Der Einreichende berichtete außerdem über einen früheren Verkauf derselben Person am 26.06.2025 von 5.877 ADS für $212.344,83. Die Mitteilung enthält die erforderliche Zusicherung, dass die veräußernde Person keine nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten besitzt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does ZLAB Form 144 report?

The filing reports a proposed sale of 1,883 ADS valued at $68,232.95, acquired via restricted stock vesting and planned for 08/18/2025 on NASDAQ.

Who is the selling person named on the ZLAB Form 144?

The filing identifies the seller as Frazor T. Edmondson for a prior sale entry and shows the current securities were acquired from the issuer as restricted stock vesting.

Were there any recent sales by the same person?

Yes. The filer reported a prior sale on 06/26/2025 of 5,877 ADS for $212,344.83.

How were the 1,883 ADS acquired?

The ADS were acquired on 08/15/2025 through restricted stock vesting from the issuer, with payment characterized as compensation.

Where will the proposed sale take place?

The notice lists the selling broker as Fidelity Brokerage Services LLC and the exchange as NASDAQ.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.73B
108.88M
1.42%
42.64%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI